Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
41.98 USD | +5.29% | +6.12% | -12.05% |
Oct. 25 | Earnings Flash (UHT) UNIVERSAL HEALTH REALTY INCOME TRUST Posts Q3 EPS $0.28 | MT |
Oct. 25 | Earnings Flash (UHT) UNIVERSAL HEALTH REALTY INCOME TRUST Posts Q3 Revenue $24.2M | MT |
Valuation
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 1 032 | 844 | 1 615 | 885 | 820 | 659 |
Enterprise Value (EV) 1 | 1 285 | 1 100 | 1 891 | 1 187 | 1 138 | 993 |
P/E ratio | 22,4x | 34,9x | 85,0x | 45,6x | 7,51x | 31,2x |
Yield | 3,51% | 4,37% | 2,32% | 4,29% | 4,71% | 5,95% |
Capitalization / Revenue | 13,8x | 10,8x | 20,4x | 11,1x | 9,53x | 7,17x |
EV / Revenue | 17,2x | 14,1x | 23,9x | 14,9x | 13,2x | 10,8x |
EV / EBITDA | 24,9x | 20,5x | 35,5x | 22,4x | 19,6x | 17,0x |
EV / FCF | 37,1x | 31,3x | 49,7x | 28,9x | -24,1x | 25,7x |
FCF Yield | 2,70% | 3,20% | 2,01% | 3,46% | -4,15% | 3,89% |
Price to Book | 4,90x | 4,25x | 8,88x | 5,57x | 3,48x | 2,88x |
Nbr of stocks (in thousands) | 13 735 | 13 746 | 13 757 | 13 771 | 13 784 | 13 802 |
Reference price 2 | 75,1 | 61,4 | 117 | 64,3 | 59,5 | 47,7 |
Announcement Date | 02/28/18 | 02/27/19 | 02/26/20 | 02/25/21 | 02/24/22 | 02/27/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 74,8 | 78,0 | 79,0 | 79,7 | 86,0 | 91,8 |
EBITDA 1 | 51,5 | 53,6 | 53,2 | 53,1 | 58,0 | 58,3 |
EBIT 1 | 26,5 | 28,9 | 27,5 | 27,7 | 30,7 | 31,9 |
Operating Margin | 35,4% | 37,0% | 34,9% | 34,8% | 35,7% | 34,7% |
Earnings before Tax (EBT) 1 | 45,6 | 24,2 | 19,0 | 19,4 | 109 | 21,1 |
Net income 1 | 45,6 | 24,2 | 19,0 | 19,4 | 109 | 21,1 |
Net margin | 61,0% | 31,0% | 24,0% | 24,4% | 127% | 23,0% |
EPS 2 | 3,35 | 1,76 | 1,38 | 1,41 | 7,92 | 1,53 |
Free Cash Flow 1 | 34,6 | 35,2 | 38,1 | 41,1 | -47,2 | 38,7 |
FCF margin | 46,3% | 45,1% | 48,2% | 51,5% | -54,9% | 42,1% |
FCF Conversion (EBITDA) | 67,2% | 65,6% | 71,5% | 77,3% | - | 66,4% |
FCF Conversion (Net income) | 75,9% | 145% | 201% | 211% | - | 183% |
Dividend per Share 2 | 2,64 | 2,68 | 2,72 | 2,76 | 2,80 | 2,84 |
Announcement Date | 02/28/18 | 02/27/19 | 02/26/20 | 02/25/21 | 02/24/22 | 02/27/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 253 | 256 | 277 | 302 | 318 | 335 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 4,91x | 4,78x | 5,20x | 5,69x | 5,48x | 5,74x |
Free Cash Flow 1 | 34,6 | 35,2 | 38,1 | 41,1 | -47,2 | 38,7 |
ROE (net income / shareholders' equity) | 22,7% | 11,8% | 9,97% | 11,4% | 55,4% | 9,09% |
Shareholders' equity 1 | 201 | 205 | 190 | 170 | 197 | 232 |
ROA (Net income/ Total Assets) | 3,26% | 3,71% | 3,54% | 3,52% | 3,51% | 3,30% |
Assets 1 | 1 400 | 653 | 536 | 552 | 3 112 | 639 |
Book Value Per Share 2 | 15,3 | 14,4 | 13,2 | 11,5 | 17,1 | 16,6 |
Cash Flow per Share 2 | 0,25 | 0,37 | 0,44 | 0,42 | 1,63 | 0,55 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 02/28/18 | 02/27/19 | 02/26/20 | 02/25/21 | 02/24/22 | 02/27/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating :
Investor Rating :
ESG Refinitiv :
C
1st Jan change | Capi. | |
---|---|---|
-12.05% | 580 M $ | |
+36.48% | 49 513 M $ | |
+3.80% | 18 802 M $ | |
-27.40% | 9 957 M $ | |
+14.92% | 7 869 M $ | |
-20.76% | 5 999 M $ | |
-53.23% | 3 118 M $ | |
-22.89% | 3 019 M $ | |
-15.55% | 2 910 M $ | |
+23.14% | 2 725 M $ |
- Stock
- Equities
- Stock Universal Health Realty Income Trust - Nyse
- Financials Universal Health Realty Income Trust